Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)
333.35
+8.55 (2.63%)
Jul 10, 2025, 3:30 PM IST
NSE:ADVENZYMES Revenue
In the fiscal year ending March 31, 2025, Advanced Enzyme Technologies had annual revenue of 6.37B INR with 2.09% growth. Advanced Enzyme Technologies had revenue of 1.67B in the quarter ending March 31, 2025, with 5.93% growth.
Revenue
6.37B
Revenue Growth
+2.09%
P/S Ratio
5.84
Revenue / Employee
18.84M
Employees
323
Market Cap
37.22B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 6.37B | 130.42M | 2.09% |
Mar 31, 2024 | 6.24B | 832.31M | 15.39% |
Mar 31, 2023 | 5.41B | 112.54M | 2.13% |
Mar 31, 2022 | 5.29B | 275.42M | 5.49% |
Mar 31, 2021 | 5.02B | 578.55M | 13.03% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UltraTech Cement | 759.55B |
Asian Paints | 338.59B |
Grasim Industries | 1,484.78B |
Vedanta | 1,513.36B |
Pidilite Industries | 131.40B |
Solar Industries India | 75.40B |
Shree Cement | 192.83B |
Jindal Steel & Power | 497.65B |
Advanced Enzyme Technologies News
- 8 months ago - Advanced Enzymes shares fall 8% after weak Q2 FY25 results - Business Upturn
- 8 months ago - Advanced Enzyme Technologies Q2 FY25: Revenue declines 7.4% YoY to ₹146.1 crore, Net Profit falls 5.1% YoY - Business Upturn